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Three-Dimensional Structure of p21 in the
Active Conformation and Analysis of an
Oncogenic Mutant
by Fred Wittinghofer,* Ute Krengel,* Jacob John,*
Wolfgang Kabsch,* and Emil F. Pai*
The three-dimensional structure ofthe active guanosine triphosphate (GTP)-a:.alogue-containing com-
plex of the H-ras-encoded p21 has been determined. It was necessary to correct the topology of p21 as
published earlier. The structure analysis shows all of the interactions between protein and GTP and how
the important cofactor Mg2e is bound. From the oncogenic mutants of p21 crystallized, a Glyl2 to Arg
mutation has been analyzed in detail. It shows that the overall structure of the mutant is not perturbed
and that the side chain ofArgl2 is coming close to the -y-phosphate for an interaction.
Introduction
The prevalence ofmutated forms ofthe ras oncogene
in human tumors makes it an attractive target to study
the function of the ras gene product p21 (1,2). These
mutations are usually point mutations in two amino
acids of the p21 sequence. It may turn out that the
malfunctioning ofmutated p21 is involved in, if not re-
sponsible for, uncontrolled growth ofcertain human tu-
mors. To understand the role ofp21 in these processes
and to design therapeutical agents directed toward mu-
tated p21, it is important to understand the structure
of this protein and its transforming mutants and the
biochemical processes it is involved in. A major focus
ofour present research is thus to investigate the struc-
ture ofp21, the structure ofoncogenic mutants, and the
guanosine triphosphate (GTP)-guanosine diphosphate
(GDP) conformational transition, which is the key re-
action of all guanine nucleotide binding proteins.
The biochemical properties ofp21 are summarized in
Table 1. Table 1 shows that p21 binds GDP/GTP with
extremely high affinity which is dependent on the pres-
ence of Mg2". It also shows that the tight binding is
specific for the guanine base and is very dependent on
the presence ofthe P-phosphate group. The affinity be-
tween guanosine monophosphate (GMP) and p21 is six
orders of magnitude lower than for GDP/GTP. The
GTPase activity of p21 is absolutely dependent on the
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Table 1. Biochemical properties of Ha-ras p21.
Binds GDP / GTP with high affinity
Ka (GDP) = 6.1 x 1011 M-' at 50C
Ka (GTP) = 1.8 x 1012 M-l at 50C
Binds GDP / GTP with high specificity
Ka (GTP) / Ka (ITP)
- 100
Ka (GDP)/Ka h6GDP
- 30
GMP affinity is approximately 106 times lower
Slow off-rates in the presence of Mg2+
Fast off-rates in the presence of EDTA
Has low intrinsic GTPase, dependent onme,
GTPase is stimulated by GAP
presence ofMg2", underscoring the importance ofthis
cofactor.
Overall Structure
We haverecentlycrystallizedthe complex ofp21 with
GDP and slowly hydrolyzing analogues of GTP:
GppNHp, GppCH2p and GTPyS (3). While the crystals
ofthe GppNHp and the GppCH2p complex are isomor-
phous, the GTP-yS crystals show a different morphol-
ogy. The P3221 crystals of the GppNHp complex are
easy to grow, very stable mechanically, and in the X-
ray beam diffract to very high resolution (at least 1.4
A). The three-dimensional structure has been revealed
usingheavy-atomisomorphousreplacementtechniques.
The electron density has been calculated at 2.5 A res-
olution, and the resultingmodel ofthe p21-GppNp com-
plex has recently been published (4).
The secondary structure elements are shown in Fig-
ure 1, together with the position of some amino acids
that are important for GTP binding, GTPase activatingWITTINGHOFER ET AL.
N
FIGURE 1. Schematic view ofthe topology ofthe three-dimensional
structure of p21 GppNHp. Some amino acids important for the
binding of nucleotide and the oncogenic activation are labeled.
Loops Li, L2, and L4 are important for GAP binding and the
GTPase activity.
protein (GAP) interaction and oncogenic activation. It
has been shown by mutational analysis that residues 32
to 40 are involved in the interaction with GAP. They
are located in loop L2 and the second n-sheet. These
residues, like Asp-33 and Asp-38, are highly exposed to
the solvent and are well defined in the structure. Since
loop L4, residues 59 to 64, is also located on the outside
ofthe molecule and very near to L2, we postulate that
this loop is also involved in the interaction with GAP.
In confirmation ofthis we have shown that the product
of the K-rev gene, which has the same sequence in L2
and a different one in L4, is not activated by GAP but
binds very tightly to it (5).
Asaresult ofourstructureanalysis, wehad tochange
the topology from the one described by DeVos et al. (6)
in the report of the structure of the GDP complex of
p21 (1-177) to the one shown in Figure 1. This topo-
logical arrangement ofsecondary structure elements is
the same as that described for the G-binding domain of
EF-Tu by LaCour et al. (7) and Jurnak (8). The differ-
ence between our structure and that of DeVos and co-
workers (6) is the arrangement ofthe second and third
p-strand and the corresponding loops. The second dif-
ference is that we find an additional helix followingloop
L4. Onthebasis ofourstructuralmodelandofsequence
alignments, it becomes more and more likely that all
guanine nucleotide binding proteins involved in signal
communication (not the enzymes like GMP-ATP phos-
photransferases) have the same three-dimensional
structure in their guanine nucleotide binding domain.
We arejust completing the high resolution structure at
1.4 A, which seems to provide us with more fascinating
details ofthe structure ofthe p21 triphosphate confor-
mation.
Nucleotide Binding Site
Thedetailsoftheinteractionoftheguaninenucleotide
with the protein are described in Figure 2. It shows all
atoms of either protein or water residues within 3.4 A
of any atom of GppNHp along with the corresponding
distances. The high affinity for GDP and GTP is re-
flected in the great number of polar interactions be-
tween the protein and the nucleotide GppNHp.
The guanine base of the nucleotide is bound by in-
teraction with the conserved elements NKXD (residues
116-119) and SAK (residues 145-147), which are con-
served in the great majority ofguanine nucleotide bind-
ing proteins (9-11). The carboxylate group of Asp-119
makes four hydrogen bonds. One oxygen interacts with
the exocyclic amino group and Wat-292; the other one
binds to the endocyclic nitrogen Ni and to the hydroxyl
of Ser-145. The keto group at position 6 ofthe guanine
base makes a hydrogen bond to the main chain -NH of
Ala-146. Asn-116, which has been proposed to be in-
volved in the binding of the 06 based on the three-
dimensional structure of EF-Tu-GDP (12), is seen here
to make stronghydrogen bonds tothe side chain ofThr-
144 and to the main chain oxygen atom of Val-14. The
mainfunctionofAsn-116isthustotietogetherthethree
elements that are involved in nucleotide binding: the
phosphate binding loop 10GXXXXGKS, the 116NKXD,
and the 146SAK motifs. It is supported by Lys-117,
which links the phosphate binding loop and the NKXD
motif by binding the main chain carbonyl of Gly-13. It
makes only weak contacts to 01 of the ribose and N7
ofthe base moiety. Another element responsible forthe
tight binding of the guanine base is the hydrophobic
interaction with the aromatic side chain of Phe-28 and
the aliphatic side chain of Lys-117 on either side ofthe
base. Phe-28 itself is also held in place by another hy-
drophobic interaction between its aromaticring and the
aliphatic side chain ofLys-147, lying on top ofthe plane
of the ring in a stretched-out conformation.
The ribose ring is in the 2'-endo conformation. The
angle X ofthe N-glycosidic bond is - 1120, which isjust
at the border of an anti-conformation for nucleotides
having the 2'-endo puckering. As reported (4), the 2'-
and 3'-hydroxyl groups of the ribose are more or less
exposed to the solvent with only weak hydrogen bonds
to the side chain ofAsp-30. The 3'-hydroxyl is involved
in an additional hydrogen bond to the main chain car-
bonyl of Val-29. 01' is weakly bound by the E-amino
group of Lys-117.
The phosphate binding site is characterized by amag-
nitude ofinteractions. Each ofthe eight phosphate oxy-
gens ofGppNHp has at leasttwo hydrogenbond donors
or the MgZ+ ion close enough for an interaction. The
hydrogen bond donors include the main chain-NH
groups of residues 13 to 18, 35, and 60, the hydroxyl
groups ofSer-17 and Thr-35, and the phenolic hydroxyl
of Tyr-32 from a neighboring p21, which contacts the
-y-phosphate. The E-amino group of Lys-16 binds to the
P-and y-phosphateoxygens, butitisclosertothelatter.
It should be mentioned that the main chain nitrogens
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FIGURE 2. Scheme for the interactions between GppNHp and p21 or water molecules. All dashed lines correspond to hydrogen bonding
interactions (below 3.4 A) between appropriate partners. The corresponding distances ofthe hydrogen bonds are given behind the residue,
except where one residue makes several bonds, in which case the distances are given on the dashed line. The distances are between the
corresponding heteroatoms.
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ofresidues 13 to 18 point toward the phosphate groups,
thereby creating a strong electrostatic field. There is a
hydrogen bond between the -NH ofGly-13 and the atom
briding the ,B- and y-phosphate, in this case GppNHp.
Since this hydrogen bond should be stronger with a
bridging oxygen atom, it is likely that this interaction
is responsible for the lower affinity ofGppNHp as com-
pared to GTP (Schlichting et al., unpublished data).
Mg2+ Binding Site
It is generally believed that phosphoryl transferases
require atleast one divalentcationforcatalytic activity,
complexed directly to phosphoryl group oxygens. One
can distinguish various possible catalytic functions of
the Mg2" ion such as shielding the negative charge on
the attacked -y-phosphate, increasing the acid strength
ofthe leaving group (J3-phosphate), or activation ofthe
nucleophile (13). Mg'+ could also be involved in the
stabilization ofthe transition state ofthe reaction. The
precise role ofthe metal ion for the quanine nucleotide
binding proteins has not been proven and may indeed
be different for each enzyme, as can be seen from the
fact that there is no preferred ligation pattern of the
metal ion to the enzyme or the phosphate atoms for
related enzymes (14). As reported before (4), Mg2' in
the three-dimensional structure of the p21-GppNHp
complex is coordinated to one oxygen ofboth the ,B- and
y-phosphate and to the side chain hydroxyl groups of
Ser-17 and Thr-35, both of which are highly conserved
FIGURE 3. Schematic drawing of the Mg binding site showing the
ligands ofthe first coordination sphere ofthe metal ion and some
ofthe interactions ofthese ligands.
in all nucleotide binding proteins. In addition, the high-
resolutionstructureproves thatAsp-57, whichistotally
conserved as part of the DXXG motif in guanine nu-
cleotide bindingproteins, is not in the first coordination
sphere ofMg2" in the triphosphate structure. Instead,
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it is hydrogen bonded to a water molecule, Wat-173,
which is directly liganded, as shown schematically in
Figure 3. Asp-57 further binds to the side chain ofSer-
17. The sixth ligand ofthe metal ion is Wat-172, which
is held in place by the interaction with the main chain
oxygen ofAsp-33 and the pro-R oxygen ofthe a-phos-
phate.
Mutated p21
Table 2 lists the nucleotide complexes ofvarious mu-
tantp21 proteinsthatwehavecrystallized andforwhich
complete data sets have been collected. Thus we have
data for four transforming mutants and mutants that
do not interact with GAP, such as p21 (D38E) (15-17).
Byusing molecularreplacement methods to solve these
structures we hope to be able to give structural expla-
nations for the different biological behavior of mutant
proteins. This should enable us and other people to pos-
sibly start with the rational design of drugs that could
interfere with the effect of transforming p21 mutants
without harmful effects on the normal protein.
The most frequent ras mutations found in human tu-
mors have a mutation of Gly-12, which is part of the
phosphate binding loop that wraps around the ,B- and
y-phosphates. It has also been shown by in vitro mu-
tagenesis studies that the mutation of Gly-12 to any
amino acid except proline renders the protein oncogenic
(18). Ithasbeenpostulated thatGly-12hassuchunusual
phi and psi angles that it cannot tolerate any side chain
Protein
Ha-ras
c'
G12V'
D38E'
D38A'
Q61H'
Q61L
Ki-ras
c'
G12V
p2Ic-p2lGl 2R
Table 2. Crystals and data sets of ras-proteins.
Data sets
Crystals collected
GDP
GMPPNP
GMPPCP
GTPyS
Caged GTP
GDP
GMPPNP
GMPPCP
GTPyS
Caged GTP
GDP
GMPPNP
GMPPCP
GTPyS
Caged GTP
GDP
GMPPNP
GDP
GMPPNP
GMPPCP
GMPPNP
GDP
GDP
GDP
p21c-p2lGl2R
(+)
+
+
+
+
+
+
+
+
+
+
+
+
+
+
A
B
FIGURE 4. Stereodrawings ofthe structure ofthe oncogenic mutant p21 (G12R) complexed to GppNHp. (A) CQ plot ofthe mutant (thick line)
in comparison to the cellular protein (thin line). (B) The phosphate binding region of the mutant protein, showing the Arg-12 side chain
interacting with y-phosphate.
p21((;I2R1, 1.1 p21(GI2R LI
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without destroyingthegeometry ofthe phosphate bind-
ing loop. We have revealed the structure of the onco-
genic mutant p21 (G12R) and find that the three-di-
mensional structure ofthe protein is very similarto the
wild-type structure, as shown in the plot of Ca coordi-
nates in Figure 4A. The only major difference between
wild-type and the G12R mutant is the large side chain
ofArg-12, which is coming close to the y-phosphate and
makes ahydrogen bondtoone phosphoryloxygen. Thus
it is reasonable to assume that this interaction is re-
sponsible for the slow dissociation rate of GTP and for
its slow GTP hydrolysis.
The interaction of p21 with GAP is governed by the
conformational transition between the GDP and GTP
bound states and this, obviously, is regulated by the
nucleotide binding site. Itis clearfromournuclearmag-
netic resonance and X-ray structural studies that there
is no major conformational change involving large parts
of the p21 molecule when the GDP and GTP (or GTP
analogue) structures are compared. By comparing the
structure of the nucleotide binding site in the triphos-
phate complex with that of the diphosphate complex,
which we are currently analyzing, we hope to be able
to give a detailed structural interpretation of the con-
formational transition at this site that is transmitted to
the site ofthe effector interaction. This conformational
change is the critical event for the functioning of all
biological processes involving G-binding proteins. Pre-
liminary experiments show that the difference between
the GDP-bound and the GTP-bound form is confined to
two subregions, loop L2 and loop L4.
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